
Oxford Genetics secures funding for DNA cloning system
Venture capital fund manager Mercia Fund Management (MFM) has invested GBP150,000 in Oxford Genetics Ltd. The new biotechnology company is behind SnapFast – a system that simplifies the purchase of synthetic DNA molecules (plasmids). Dr Ryan Cawood, chief executive of Oxford Genetics, invented the SnapFast system and likens

